Nonetheless, whether the α‐LA‐induced repression of EGFR or Met signalling of HCC cells occurs through attenuation of Grb2‐associated‐binding events to block growth factor‐stimulated Grb2 signalling or an immediate suppression of the activation of EGFR or Met signalling, which limits the growth and proliferation of cells, needs to be explored further. The gene discussed is GRB2; the disease is hepatocellular carcinoma.